Senator Warren Urges U.S. Patent Office To Scrutinize Merck's Keytruda
U.S. Senator Elizabeth Warren sent the nation's top patent regulator a letter urging close scrutiny of Merck & Co's requests for new patents on its blockbuster cancer treatment Keytruda, saying further efforts to protect the drug could be an abuse of the system.